The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in France

Mickael Hiligsmann; Jean-Yves Reginster

doi:10.1080/14737167.2017.1375406

The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in France

Mickael Hiligsmann^*, Jean-Yves Reginster

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	191-195
Number of pages	5
Journal	Expert Review of Pharmacoeconomics & Outcomes Research
Volume	18
Issue number	2
DOIs	https://doi.org/10.1080/14737167.2017.1375406
Publication status	Published - 1 Jan 2018

Keywords

Cost-effectiveness
dairy products
fractures
France
osteoporosis
projections
public health
POSTMENOPAUSAL WOMEN
COST-EFFECTIVENESS
OSTEOPOROSIS
SUPPLEMENTATION

Access to Document

10.1080/14737167.2017.1375406

Cite this

@article{80e3c41d6aa04d60acb2595b9aec69b6,

title = "The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in France",

keywords = "Cost-effectiveness, dairy products, fractures, France, osteoporosis, projections, public health, POSTMENOPAUSAL WOMEN, COST-EFFECTIVENESS, OSTEOPOROSIS, SUPPLEMENTATION",

author = "Mickael Hiligsmann and Jean-Yves Reginster",

year = "2018",

month = jan,

day = "1",

doi = "10.1080/14737167.2017.1375406",

language = "English",

volume = "18",

pages = "191--195",

journal = "Expert Review of Pharmacoeconomics & Outcomes Research",

issn = "1473-7167",

publisher = "Routledge/Taylor & Francis Group",

number = "2",

}

TY - JOUR

T1 - The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in France

AU - Hiligsmann, Mickael

AU - Reginster, Jean-Yves

PY - 2018/1/1

Y1 - 2018/1/1

KW - Cost-effectiveness

KW - dairy products

KW - fractures

KW - France

KW - osteoporosis

KW - projections

KW - public health

KW - POSTMENOPAUSAL WOMEN

KW - COST-EFFECTIVENESS

KW - OSTEOPOROSIS

KW - SUPPLEMENTATION

U2 - 10.1080/14737167.2017.1375406

DO - 10.1080/14737167.2017.1375406

M3 - Article

C2 - 28862051

VL - 18

SP - 191

EP - 195

JO - Expert Review of Pharmacoeconomics & Outcomes Research

JF - Expert Review of Pharmacoeconomics & Outcomes Research

SN - 1473-7167

IS - 2

ER -